March 19, 2018

Philips convenes the 2018 Annual General Meeting of Shareholders

AGM agenda includes proposals to appoint Paul Stoffels and to re-appoint Orit Gadiesh as members of the Supervisory Board
AGM to be held on May 3, 2018

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2018 Annual General Meeting of Shareholders (AGM) and publishes the agenda with explanatory notes. The agenda includes proposals to appoint Paul Stoffels and to re-appoint Orit Gadiesh as members of the Supervisory Board.

In view of Philips’ transformation to a focused health technology company and its pivot to innovative value-added integrated solutions, the Supervisory Board proposes to appoint Mr Stoffels (1962, Belgian) as a member of the Supervisory Board per August 1, 2018. Mr Stoffels has in-depth knowledge across the pharmaceutical, medical device and consumer segments and has led teams to develop transformational new medicines and healthcare solutions. Mr Stoffels is currently Chief Scientific Officer at Johnson & Johnson, where he is also a member of its Executive Committee and chair of its R&D Management Committee.

Ms Gadiesh (1951, Israeli/American) is recommended to be re-appointed in view of her in-depth knowledge of marketing, technological developments and international business, which have proven to be valuable in the way she fulfils her role since 2014 as member of the Supervisory Board and Audit Committee. Subject to her re-appointment, Ms Gadiesh will retain her current position within the Audit Committee.

The AGM will be held at the Hotel Okura Amsterdam (Ferdinand Bolstraat 333, Amsterdam) on Thursday May 3, 2018, beginning at 14:00 hours CET.

Click here to view agenda with explanatory notes, the Annual Report 2017 (which was published on February 20, 2018), the binding recommendations and other documents relevant for the AGM.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.